I believe this is the second quarter update that I listened to on CELG, I think the first one had a little bit on vidaza, but Celg had just acquired PHRM. I didn't sense they were scared of Dacogen, they hold the EU cards right now and that's not going away real soon. Eisai update at the end of the month will gives us more insight into what may develope and what plans JNJ has for dacogen. I was surprised we haven't seen onc,inc give their mid month update. They seemed to be aligned with vidaza and normally give their figures.